WeVote

Bill

Bill

SB 87

OPIOID ADDICTION PREVENTION

2026 Regular Session Introduced by Craig Brandt

SB 87 pursues opioid addiction prevention in New Mexico through legislative action requiring committee review of health, regulatory, and fiscal implications.

action postponed indefinitely
0
WeVote Research Nonpartisan
Bill Summary · SB 87

Legislative bill overview

SB 87 proposes opioid addiction prevention measures in New Mexico, though the specific provisions are not detailed in the available information. The bill has been referred to three Senate committees (Committee, Health and Public Affairs, and Finance), suggesting it involves regulatory, health, and fiscal considerations. As introduced by Senator Craig Brandt, it represents a legislative response to opioid-related public health concerns.

Why this is important

Opioid addiction remains a significant public health crisis affecting treatment access, overdose mortality rates, and community safety across New Mexico and the nation. Prevention-focused legislation can address upstream causes of addiction, potentially reducing downstream costs to healthcare, criminal justice, and social services systems. The bill's referral to the Finance Committee indicates substantial fiscal implications worth public scrutiny.

Potential points of contention

  • Prevention approach specificity: Without known details, unclear whether the bill emphasizes education, prescriber regulations, medication access, or other mechanisms—each carrying different stakeholder support levels
  • Funding and implementation costs: Finance Committee referral suggests new expenditures; questions about funding sources and program effectiveness measurement will likely arise
  • Balance between access and restriction: Opioid prevention bills often face tension between limiting prescription opioids (affecting pain patients) and ensuring access for legitimate medical needs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.